logo-loader

Bellevue Healthcare Trust Paul Major discusses US healthcare potential under Trump

Published: 15:52 13 Nov 2024 GMT

Bellevue Healthcare Trust PLC (LSE:BBH) co-portfolio manager Paul Major spoke with Proactive's Stephen Gunnion about the implications of Donald Trump and the Republicans' victory in the recent US election on the healthcare sector.

Major explained that while initial reactions may predict challenges due to inflationary pressures, a more nuanced analysis points to potential benefits, particularly in M&A activity. He noted, “The licensing and acquisition of new products is the lifeblood of big pharma,” emphasising that a reduction in antitrust actions could spur large-scale mergers and acquisitions, catalysing interest in the biotech sector.

Major highlighted that despite inflation concerns, healthcare fundamentals remain strong due to consistent demand and demographic trends.

Bellevue Healthcare Trust’s Paul Major: small cap healthcare's big opportunity

Bellevue Healthcare Trust PLC (LSE:BBH) co-portfolio manager Paul Major tells Proactive's Stephen Gunnion about the potential benefits for the healthcare sector as tech stocks lose their lustre. Major discussed how the long-overdue rotation from tech could positively impact healthcare,...

on 20/8/24
OSZAR »